Clinical Trial

The Analysis of Efficacy Factors for Autologous Platelet-Rich Plasma Therapy in the Treatment of Elbow Tendinopathy

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 7, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
To identify key factors influencing the effectiveness of platelet-rich plasma (PRP) therapy in treating elbow tendinopathy, a common degenerative condition.
Trial Details
NCT Number NCT06815042
Lead Sponsor CHA University
Conditions Elbow Tendinopathy
Enrollment 30 participants
Start Date 2025-02
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-02-07